Unity Biotechnology Inc (UBX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.9770 -0.0067 (-0.68%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.0200 +0.0430 (+4.40%) 16:21 ET
for Fri, Apr 25th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,990 | -39,860 | -44,469 | -60,725 | -93,844 |
| Depreciation Amortization | 2,821 | 5,986 | 3,222 | 4,736 | 6,652 |
| Accounts payable and accrued liabilities | -383 | -410 | -194 | -573 | -2,640 |
| Other Working Capital | 3,391 | -4,391 | -1,022 | -631 | -4,554 |
| Other Operating Activity | -704 | 1,587 | -9,951 | 12,133 | 16,053 |
| Operating Cash Flow | $-20,865 | $-37,088 | $-52,414 | $-45,060 | $-78,333 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 26 | 104 | 282 | -195 | -646 |
| Purchase Of Investment | -23,711 | -28,609 | -98,827 | -81,492 | -138,486 |
| Sale Of Investment | 32,250 | 89,000 | 74,000 | 121,000 | 133,924 |
| Investing Cash Flow | $8,565 | $60,495 | $-24,545 | $39,313 | $-5,208 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 210 | 374 |
| Debt Repayment | N/A | -20,000 | N/A | -68 | 24,505 |
| Common Stock Issued | 77 | 4,498 | -1,825 | 2,131 | 2,086 |
| Other Financing Activity | 0 | -838 | 58,065 | 18,572 | 36,910 |
| Financing Cash Flow | $77 | $-16,340 | $56,240 | $20,845 | $63,875 |
| Beginning Cash Position | 20,699 | 13,632 | 34,351 | 19,253 | 38,919 |
| End Cash Position | 8,476 | 20,699 | 13,632 | 34,351 | 19,253 |
| Net Cash Flow | $-12,223 | $7,067 | $-20,719 | $15,098 | $-19,666 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,865 | -37,088 | -52,414 | -45,060 | -78,333 |
| Capital Expenditure | N/A | -11 | -96 | -195 | -646 |
| Free Cash Flow | -20,865 | -37,099 | -52,510 | -45,255 | -78,979 |